全文获取类型
收费全文 | 1803篇 |
免费 | 251篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 60篇 |
妇产科学 | 30篇 |
基础医学 | 98篇 |
口腔科学 | 74篇 |
临床医学 | 286篇 |
内科学 | 430篇 |
皮肤病学 | 103篇 |
神经病学 | 71篇 |
特种医学 | 296篇 |
外科学 | 134篇 |
综合类 | 25篇 |
预防医学 | 314篇 |
眼科学 | 13篇 |
药学 | 36篇 |
肿瘤学 | 96篇 |
出版年
2023年 | 48篇 |
2022年 | 14篇 |
2021年 | 15篇 |
2020年 | 42篇 |
2019年 | 19篇 |
2018年 | 53篇 |
2017年 | 34篇 |
2016年 | 48篇 |
2015年 | 55篇 |
2014年 | 100篇 |
2013年 | 127篇 |
2012年 | 43篇 |
2011年 | 55篇 |
2010年 | 67篇 |
2009年 | 81篇 |
2008年 | 49篇 |
2007年 | 74篇 |
2006年 | 52篇 |
2005年 | 44篇 |
2004年 | 47篇 |
2003年 | 18篇 |
2002年 | 18篇 |
2001年 | 34篇 |
2000年 | 26篇 |
1999年 | 35篇 |
1998年 | 67篇 |
1997年 | 89篇 |
1996年 | 79篇 |
1995年 | 57篇 |
1994年 | 63篇 |
1993年 | 52篇 |
1992年 | 18篇 |
1991年 | 16篇 |
1990年 | 36篇 |
1989年 | 45篇 |
1988年 | 37篇 |
1987年 | 38篇 |
1986年 | 36篇 |
1985年 | 36篇 |
1984年 | 17篇 |
1983年 | 15篇 |
1982年 | 28篇 |
1981年 | 37篇 |
1980年 | 26篇 |
1979年 | 11篇 |
1978年 | 8篇 |
1977年 | 16篇 |
1976年 | 14篇 |
1975年 | 10篇 |
1971年 | 6篇 |
排序方式: 共有2075条查询结果,搜索用时 33 毫秒
101.
Cholera disease can be induced in the rabbit by ligation of the cecum (C) followed by duodenal inoculation (DI) of virulent Vibrio cholerae organisms (DIC model). When the cecum is not ligated, DI does not induce disease. In contrast, the animals are primed which becomes apparent upon challenge with live V. cholerae in the DIC model. Such animals are vibriocidally protected. This protection is characterized by absence of disease symptoms, rapid disappearance of V. cholerae from the feces and presence of high levels of anti-lipopolysaccharide Immunoglobulin A in the bile. The present study shows that primed rabbits can also be boosted by duodenal administration of killed, smooth V. cholerae cells. On the other hand, killed cells cannot prime. The minimal lethal dose of a rough derivative of a smooth strain C5, designated R5 and lacking the O antigen part of the LPS, was 100,000 times higher than that of its parent strain C5, in the DIC model. Rabbits which had been duodenally immunized with strain R5 and were subsequently challenged with the smooth strain C5, all developed diarrhea and two out of eight died. This result supports an earlier observation that the specific O antigen part of the V. cholerae LPS is an essential prerequisite for the induction of protective immunity in the rabbit. 相似文献
102.
C. Santos A. López‐Doriga M. Navarro J. Mateo S. Biondo M. Martínez Villacampa G. Soler X. Sanjuan M. J. Paules B. Laquente E. Guinó E. Kreisler R. Frago J. R. Germà V. Moreno R. Salazar 《Colorectal disease》2013,15(4):414-422
Aim Adjuvant 5‐fluorouracil based chemotherapy has demonstrated benefit in Stage III colon cancer but still remains controversial in Stage II. The aim of this study was to analyse the prognostic impact of clinicopathological factors that may help guide treatment decisions in Stage II colon cancer. Method Between 1996 and 2006 data from patients diagnosed with colorectal cancer at Hospital Universitari Bellvitge and its referral comprehensive cancer centre Institut Català d′Oncologia/L’Hospitalet were prospectively included in a database. We identified 432 patients with Stage II colon cancer operated on at Hospital Universitari Bellvitge. The 5‐year relapse‐free survival (RFS) and colon‐cancer‐specific survival (CCSS) were determined. Results The 5‐year RFS and CCSS were 83% and 88%, respectively. Lymphovascular or perineural invasion was associated with RFS [hazard ratio (HR) 1.84; 95% CI 1.01–3.35]. Gender (women, HR 0.48; 95% CI 0.23–1) and lymphovascular or perineural invasion (HR 3.51; 95% CI 1.86–6.64) together with pT4 (HR 2.79; 95% CI 1.44–5.41) influenced CCSS. In multivariate analysis pT4 and lymphovascular or perineural invasion remained significantly associated with CCSS. We performed a risk index with these factors with prognostic impact. Patients with pT4 tumours and lymphovascular or perineural invasion had a 5‐year CCSS of 61%vs the 93% (HR 5.87; 95 CI 2.46–13.97) of those without any of these factors. Conclusion pT4 and lymphatic, venous or perineural invasion are confirmed as significant prognostic factors in Stage II colon cancer and should be taken into account in the clinical validation process of new molecular prognostic factors. 相似文献
103.
104.
105.
J Broadmore JD Hutton F Langdana 《BJOG : an international journal of obstetrics and gynaecology》2009,116(5):731-733
Medical students usually initially learn vaginal examination (VE) by examining consenting anaesthetised women. To assess their experience of this practice, a questionnaire was distributed to all 66 fifth-year students at the Wellington School of Medicine in 2005—53 students responded. Although 184 women were available to approach for consent, only 141 were approached—students claimed insufficient time as their major difficulty. All male students discussed consent with women only in the 2 hours preoperatively, whereas nine (28%) of the female students sought consent earlier on the day or the day before. Of the 114 women asked, 97 gave written consent, but the VE was conducted in only 76 women mostly because the supervising gynaecologist claimed time constraints or was uninterested. Four other women were examined when consent was uncertain and two without consent. All but one of the students considered the experience educationally valuable. Eleven responding students did not perform a VE, and if the 13 nonresponders also did not, more than one-third of students lack this educational opportunity prior to their final year. In conclusion, some students require more commitment to seeking consent, and some gynaecologists may need to better facilitate this learning opportunity so that the consent agreed with the woman and student is more often respected. 相似文献
106.
107.
C Badenas J To-Figueras JD Phillips CA Warby C Muñoz and C Herrero 《Clinical genetics》2009,75(4):346-353
Porphyria cutanea tarda (PCT) arises from decreased hepatic activity of uroporphyrinogen decarboxylase (UROD). Both genetic and environmental factors interplay in the precipitation of clinically overt PCT, but these factors may vary between different geographic areas. Decreased activity of UROD in erythrocytes was used to identify patients with UROD mutations among a group of 130 Spanish PCT patients. Nineteen patients (14.6%) were found to harbor a mutation in the UROD gene. Eight mutations were novel: M1I, 5del10, A22V, D79N, F84I, Q116X, T141I and Y182C. Five others were previously described: F46L, V134Q, R142Q, P150L and E218G. The new missense mutations and P150L were expressed in Escherichia coli. D79N and P150L resulted in proteins that were localized to inclusion bodies. The other mutations produced recombinant proteins that were purified and showed reduced activity (range: 2.3–73.2% of wild type). These single amino acid changes were predicted to produce complex structural alterations and/or reduced stability of the enzyme. Screening of relatives of the probands showed that 37.5% of mutation carriers demonstrated increased urinary porphyrins. This study emphasizes the role of UROD mutations as a strong risk factor for PCT even in areas where environmental factors (hepatitis C virus) have been shown to be highly associated with the disease. 相似文献
108.
109.
110.